← All tickers

Is BSX Worth Buying in 2026?

Boston Scientific Corp.

STOCK SURGICAL & MEDICAL INSTRUMENTS & APPARATUS Updated 2026-08-23

Here’s whether Boston Scientific Corp. (BSX) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Caution.

🟡
Caution

Positives: above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+1.14% over 10 days); RSI 58 — healthy momentum range. Concerns: trading below the 200-day MA (long-term downtrend); weak 1-year return of -52.1%; 3-month momentum negative (-12.8%). Currently 54.0% off its 52-week high. Score: -1/7.

Ready to act on this? 📈 Trade on Webull

BSX is trading below its 200-day MA ($69.43) — a key warning sign the longer-term trend is under pressure. An RSI of 57.7 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -52.1% compares to +20.5% for SPY (trailed the market by 72.6%). The current 54.0% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $4,788 today
vs. S&P 500 (SPY) — same period trailed market by 72.6%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

✗Above 200-day MA ($69.43)
✓Above 50-day MA ($46.42)
✓RSI(14) neutral zone (30–70) — currently 57.7
✗Positive return (-52.1%)
!Within 10% of period high (−54.0%)
Period Range $50.37
$42.20 $109.50
RSI (14) 57.7
0 · OversoldOverbought · 100

Key Metrics

Price$50.37
Period Return-52.1%
Period High$109.50
Period Low$42.20
Drawdown−54.0%
MA-50$46.42
MA-200$69.43
RSI (14)57.7
Avg Volume (30d)19.7M
vs. SPYtrailed by 72.6%
Return Rank#900 of 999

Trade BSX

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers